Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The Cochrane Database of Systematic Reviews
|
October 8, 2014
Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Maximilian Huhn, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
September 2, 2014
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Markus Dold, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
August 4, 2014
Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Maximilian Huhn, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
July 9, 2014
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Markus Dold, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
July 10, 2014
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Maximilian Huhn, Werner Kissling, et al.
The Cochrane Database of Systematic Reviews
|
January 17, 2015
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
Markus Dold, Myrto T Samara, Chunbo Li, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Benzodiazepines for schizophrenia
Markus Dold, Chunbo Li, Magdolna Tardy, et al.
The Cochrane Database of Systematic Reviews
|
May 18, 2012
Maintenance treatment with antipsychotic drugs for schizophrenia
Stefan Leucht, Magdolna Tardy, Katja Komossa, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 27, 2016
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials
Markus Dold, Magdolna Tardy, Myrto T Samara, et al.
Lancet (London, England)
|
May 8, 2012
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Stefan Leucht, Magdolna Tardy, Katja Komossa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The Cochrane Database of Systematic Reviews
|
October 8, 2014
Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Maximilian Huhn, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
September 2, 2014
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Markus Dold, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
August 4, 2014
Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Maximilian Huhn, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
July 9, 2014
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Markus Dold, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews
|
July 10, 2014
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia
Magdolna Tardy, Maximilian Huhn, Werner Kissling, et al.
The Cochrane Database of Systematic Reviews
|
January 17, 2015
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
Markus Dold, Myrto T Samara, Chunbo Li, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Benzodiazepines for schizophrenia
Markus Dold, Chunbo Li, Magdolna Tardy, et al.
The Cochrane Database of Systematic Reviews
|
May 18, 2012
Maintenance treatment with antipsychotic drugs for schizophrenia
Stefan Leucht, Magdolna Tardy, Katja Komossa, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 27, 2016
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials
Markus Dold, Magdolna Tardy, Myrto T Samara, et al.
Lancet (London, England)
|
May 8, 2012
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Stefan Leucht, Magdolna Tardy, Katja Komossa, et al.
Page
of 2